Today’s CSR movers
SRE 4.1 ▲ 1.2
ES 3.0 ▲ 0.8
EIX 3.1 ▲ 0.8
AMZN 4.7 ▲ 0.1
GS 2.3 ▼ 0.8
WEC 2.6 ▼ 1.2
ETR 2.9 ▼ 1.2
C 2.8 ▼ 1.2
PCG 2.9 ▼ 1.2
FOX 2.4 ▼ 1.5
Health Care · NYSE NYSE · MTD

Mettler Toledo

$1,273.77 -$35.28 -2.77% CLOSE 07.20.26 AFTER HOURS $1,273.77
Convergence score
3.7 / 5.0 BULLISH
+0.0 vs last report
Overall valuation
Overvalued
Aggregated across multiple horizons
Consensus target (12mo)
$1,357.35 +6.6%
Range $1,194.00 — $1,600.00
Sector
Health Care
NYSE · Tracked daily
Today's snapshot

Where the signals stand.

REPORT 07.20.26
UV Convergence Score
REPORT 07.20.26
3.7
/ 5.0
BULLISH
Consensus signal A
4.0
Consensus signal B
3.0
Consensus signal D
4.0
Rating trend signal
3.9
Analyst average
3.9
Multi-signal aggregate How CSR works →
Day Range
$1,269.21 – $1,295.80
52W Range
$1,023.05 – $1,525.17
Volume
139.1K
Avg Vol
204.1K
Mkt Cap
$25.74B
P/E
29.91
EPS (TTM)
$42.58
Div Yield
Beta
1.25
Today's convergence

Convergence score sits at 3.7 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation
Overvalued
CSR direction
BULLISH
Last close
$1,273.77
Sector
Health Care
Valuation
Three horizons
UPDATED 07.20.26
Short term
0–3 MO
No target Moderate Buy
Medium term
3–12 MO
$1,409+10.6% Hold
Long term
12–36 MO
$763.93-40.0% Overvalued
Open valuation
Analysts
Coverage & consensus
4 PANELS
Mean target (12mo)
$1,357.35 +6.6%
RANGE $1,194.00 — $1,600.00
Analyst consensus
Consensus rating Buy
Blended score 3.7 / 5
Analysts tracked 51
Open analysts
Financials
Key metrics
LATEST
P/E
29.91
EPS (TTM)
$42.58
Mkt Cap
$25.74B
Div Yield
Beta
1.25
52W Range
$1,023.05 – $1,525.17
Open financials
Reports
Login for history

Sign in to view the historical report archive for this stock.

Log in
Valuation breakdown

Three horizons, one consensus.

UPDATED 07.20.26
Short term
0–3 MO
Moderate Buy
Consensus target
No target available

Current analyst consensus rating from Barchart.

Medium term
3–12 MO
Hold
Consensus target
$1,409 +10.6%
RANGE $1,194 – $1,600
$1,194NOW $1,273.77$1,600

12-month analyst consensus target across covering brokerages.

Long term
12–36 MO
Overvalued
Consensus target
$763.93 -40.0%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0
Analyst coverage

Blended analyst consensus & targets.

4 PANELS · UPDATED 07.20.26
Analyst consensus
Rating Blended score Panels Analysts
Buy 3.7 4 51
Price targets
Coverage Low Mean Median High Upside
All panels $1,194.00 $1,357.35 $1,324.00 $1,600.00 +6.6%
Rating distribution
Coverage SB B H S SS
All panels 2 11 13 0 0
Rating trend
Period Rating Avg Analysts
Current Moderate Buy 3.92 13
1 Mo Ago Moderate Buy 3.92 13
2 Mo Ago Moderate Buy 3.92 13
3 Mo Ago Moderate Buy 3.92 13
Most recent analyst action
Date
7/7/2026
Firm
Weiss Ratings
Action
Reiterated Rating
Rating
Hold (C)
Target
Financials

Full financial snapshot.

UPDATED 07.20.26
Quote snapshot
Prev Close
$1,310.02
Open
$1,295.35
Day Low
$1,269.21
Day High
$1,295.80
Bid
$1,269.97
Ask
$1,320.71
52W Low
$1,023.05
52W High
$1,525.17
50D Avg
$1,185.68
200D Avg
$1,316.27
Volume
139.1K
Avg Vol
204.1K
10D Avg Vol
135.0K
52W Change
12.31%
S&P 52W Change
18.27%
Valuation ratios
P/E (TTM)
29.91
P/E (Fwd)
24.84
PEG (Fwd)
2.75
P/S
6.29
P/B
Book Value
$-2.07
EV/Revenue
6.82
EV/EBITDA
22.92
Mkt Cap
25.74B
Enterprise Val
27.91B
Profitability & returns
Profit Margin
21.40%
Gross Margin
59.19%
Operating Margin
23.29%
EBITDA Margin
29.77%
Return on Assets
20.57%
Return on Equity
Growth
Revenue Growth (YoY)
7.20%
Earnings Growth (YoY)
6.70%
Earnings Growth (Q)
3.60%
Balance sheet & cash flow
Total Revenue
4.09B
EBITDA
1.22B
Total Cash
60.57M
Total Debt
2.23B
Cash / Share
$3.00
Revenue / Share
$199.85
Free Cash Flow
615.04M
Operating CF
901.12M
Debt / Equity
Current Ratio
1.20
Quick Ratio
0.69
Dividend
Fwd Dividend
Dividend Yield
Payout Ratio
0.00%
5Y Avg Yield
Ex-Div Date
Share statistics
Shares Out
20.21M
Float
20.1M
Shares Short
736.33k
% Short of Float
4.18%
Short Ratio
3.15
% Held Insiders
0.43%
% Held Institutions
103.46%
Calendar & events
Next Earnings
2026-07-30
Fiscal Year End
2025-12-31
Most Recent Qtr
2026-03-31
Last Split
Split Date
Company
Industry
Diagnostics & Research
Employees
16,600